Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games

HONG KONG, Aug 18, 2025 – (ACN Newswire via SeaPRwire.com) – On August 17, 2025, the inaugural World Humanoid Robot Games—an international event centered on humanoid robots—concluded successfully at the National Speed Skating Oval in Beijing, also known as the “Ice Ribbon.” Co-hosted by the Beijing Municipal Government, China Media Group, the World Robot Cooperation Organization, […]

Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games

HONG KONG, Aug 18, 2025 – (ACN Newswire via SeaPRwire.com) – On August 17, 2025, the inaugural World Humanoid Robot Games—an international event centered on humanoid robots—concluded successfully at the National Speed Skating Oval in Beijing, also known as the “Ice Ribbon.” Co-hosted by the Beijing Municipal Government, China Media Group, the World Robot Cooperation Organization, […]

How Do AI Workflow Automations Work?

SINGAPORE, Aug 16, 2025 – (ACN Newswire via SeaPRwire.com) – A 2022 survey from Vanson Bourne revealed that around 91%1 of respondents saw increased demand for automation from business teams. As AI technology evolves, that demand will only grow. AI automations can help organizations work smarter at every level. But how exactly do these workflows […]

How Do AI Workflow Automations Work?

SINGAPORE, Aug 16, 2025 – (ACN Newswire via SeaPRwire.com) – A 2022 survey from Vanson Bourne revealed that around 91%1 of respondents saw increased demand for automation from business teams. As AI technology evolves, that demand will only grow. AI automations can help organizations work smarter at every level. But how exactly do these workflows […]

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application (NDA) for VELSIPITY(R) (etrasimod) for the treatment of patients with moderately to severely active ulcerative colitis (UC). Building on prior approvals in Singapore, […]

Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC

HONG KONG, Aug 15, 2025 – (ACN Newswire via SeaPRwire.com) -?Everest Medicines today announced that etrasimod (VELSIPITY(R)) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults (the ?Updated Guidelines?). Etrasimod, an S1P receptor modulator, is recommended for the induction of remission in patients with moderately to severely active UC and for […]

Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC

HONG KONG, Aug 15, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines today announced that etrasimod (VELSIPITY(R)) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults (the “Updated Guidelines”). Etrasimod, an S1P receptor modulator, is recommended for the induction of remission in patients with moderately to severely active UC and for […]

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application (NDA) for VELSIPITY(R) (etrasimod) for the treatment of patients with moderately to severely active ulcerative colitis (UC). Building on prior approvals in Singapore, […]

Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Yuexiu Real Estate Investment Trust (“Yuexiu REIT”, together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 405) announced its interim results for the six months ended 30 June 2025. Yuexiu REIT Management Team: Chairman and Non-Executive Director Mr. JIANG […]

OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively

Results Highlights: – Revenue reached US$83.6 million, a year-on-year increase of 5.9%.– Sales volume reached 919,000 units, of which 779,000 units were proprietary products, representing a year-on-year increase of 8.6%.– Profit attributable to owners of the company increased by 5.1% year-on-year to US$19.8 million.– Core operating profit amounted to US$15.1 million, an increase of 11.4% […]

NMPA Accepted Essex’s Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration

HONG KONG, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – Essex Bio-Technology Limited (“Essex” or the “Group”, Stock Code: 1061.HK) is pleased to announce that a Biologics License Application (“BLA”) for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal antibody injection, has recently been accepted by the Centre for Drug Evaluation (“CDE”) of the National Medical […]

Re-opening of Food Expo and concurrent fairs

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Following the lifting of the Black Rainstorm Warning Signal at 11:10am, the Food Expo, Beauty & Wellness Expo, Home Delights Expo, Food Expo PRO and Hong Kong International Tea Fair will reopen at 1:10pm. The Food Expo, Beauty & Wellness Expo, Home Delights Expo […]

WL Delicious Announced 2025 Interim Results

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Weilong Delicious Global Holdings Ltd (“WL Delicious” or the “Company”) and together with its subsidiaries (the “Group”) (Hong Kong stock code: 9985.HK) announced its unaudited interim results for the six months ended 30 June 2025 (the “Reporting Period”). RMB For the 6 months ended 30 […]

Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products

HONG KONG, Aug 11, 2025 – (ACN Newswire via SeaPRwire.com) – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited interim results for the six months ended June 30, 2025. The Company demonstrated robust growth momentum and significant operational […]